Dosing & Administration
This unit explains, for education only, how amycretin was dosed in its trials, so you can understand the published…
The trial schedules, and why you cannot buy it
This unit explains, for education only, how amycretin was dosed in its trials, so you can understand the published research. It is not a protocol or a recommendation. Amycretin is not approved in the United States, and the only supply any source in this course describes is Novo Nordisk's own clinical trials.
The honest throughline: the only real dosing information comes from the trials, both formulations climb the dose slowly, and anything sold online as "research peptide" amycretin is unverified, with no compounding route shown to reach it.
Key terms
The trial-validated schedules
The only legitimate dosing information for amycretin comes from its trials, and it is presented here as research context, not a prescription. The two formulations differ: the oral tablet is once daily, the subcutaneous injection is once weekly, and both climb the dose in steps over weeks.
Two points matter most. First, the optimal maintenance dose is not yet established, because these were dose-finding trials, not confirmatory ones. Second, these figures describe a product given to participants inside a trial, not a number anyone should act on with an online vial.
This unit is education only and not medical advice. The trial regimens are research reference information, not a recommendation to use amycretin.